About the meeting
The ICCBH biennial conference is firmly established on the international meeting calendar and regularly attracts audiences in excess of 600 delegates to hear about and discuss the latest research into paediatric bone disorders. The next ICCBH conference is due to take place in Dublin, Ireland, on 2-5 July 2022 (postponed from 2021). Our focus is on supporting this growing community and in view of this a virtual meeting on bone fragility disorders will be organised for 18-20 November 2020.
The Virtual Forum will comprise invited lectures, meet the expert sessions, workshops, clinical case discussions, oral communications, poster discussions and networking sessions.
The aim is to present and discuss new research in investigative, diagnostic and therapeutic management of patients with bone fragility disorders and to foster the exchange of ideas and discussion of ongoing initiatives.
The focus will be on provision of engaging content and networking opportunities for a global audience.
The meeting is organised in association with ECTS, OIF and OIFE. OIF will organise a Virtual Young Investigators’ Symposium as a pre-meeting to the ICCBH Virtual Forum. Details on the OIF website.
Download the programme book here
(includes the full programme, invited speaker details and other meeting information)
For a quick overview of the programme please see below:
Times shown are Central European Time (CET)
ICCBH New Investigator Networking Group meeting
Organisers: Adalbert Raimann (Vienna, Austria) & Marie-Eve Robinson (Ottawa, Canada)
Paediatric Bone Health: navigating the path to a meaningful career
Followed by discussion and networking
OIF Young Investigator Symposium
(separate platform, accessed through the OIF website)
Sessions will be recorded and made available until 31 December 2020 for delegates to revisit or to view in their own time.
Continuing Medical Education (CME)
The meeting is approved for 14 CME credits by the European Accreditation Council for Continuing Medical Education (EACCME) under code LEE20-01198.
Guidelines for speakers and poster presenters
Please follow the links below to access the presentation and moderator instructions:
Abstract and clinical case submission
The abstract deadline has passed. Thank you to all who submitted work for consideration for presentation at the meeting. Acceptance notifications will be sent out on 16 October.
In case you have any queries about abstract or clinical case submissions please do not hesitate to contact us.
Abstracts will be published in JBMR Plus.
Presenting at the virtual forum will give you an opportunity to network with a global audience and in particular to:
- Showcase your current work
- Get support and feedback from others
- Raise your profile among colleagues internationally and from multiple disciplines
- Widen your network to open up new opportunities for future collaborations
New Investigator Awards
Two New Investigator Awards will be offered according to mean score achieved during the blind reviewing process. Awards winners will be notified by email on 16 October 2020.
To be eligible an author must be:
- First and presenting author
- Must be in training or within 3 years of attaining PhD or MD or equivalent and/or aged under 35
There is a box on the abstract form for confirmation of eligibility.
Best Poster Awards
In addition there will be awards for the two Best Posters, as selected by the meeting attendees.
Standard registration: €150
Reduced registration: €90*
A late registration fee of €30 will apply to registrations received after 23:59 CET on 30 October 2020.
To register at the discounted rate you must be one of the following:
- an undergraduate
- a current MD/PhD student
- within 5 years of obtaining an MD/PhD
- an Allied Health Professional
- a registered patient group representative*
- based in a low or developing income country (see list)
The meeting programme is designed for healthcare professionals and researchers. Pharma industry regulations do not allow open invitations to members of the public to attend. However, patient organisation representatives are encouraged to register to attend the meeting provided they meet the following criteria:
- They represent a formally registered international organisation with elections (or national with some international activities) and
- They are a member of the management group or are officially nominated by the management group or are a paid member of staff
Cancellations will be accepted in writing until 23:59 on Friday 6 November, until which time a 70% refund will be given. There will be no refunds for cancellations received after this date.
Any Italian pharmaceutical company supporting or participating in a congress abroad, is subjected to an authorization by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124).
The authorisation request must be submitted within 70 days before the start date of the event. The appointed agency to collect all applications from pharmaceutical companies and file them with the AIFA is:
Alijet & Fargo International Srl
Via P. Maroncelli 44-46-48-50
50137 FIRENZE, Italy
The meeting will offer a high quality scientific programme of interest to both clinical and basic scientists.
Attendees will be from a multidisciplinary background, including paediatricians, endocrinologists, rheumatologists, nephrologists, nutritionists, orthopaedic surgeons and others, giving you the opportunity to raise your profile with a broad global audience.
To discuss please contact us.
1 October 2020
16 October 2020
30 October 2020
16 November 2020
18-20 November 2020
Confirmations to authors
Late registration period begins
Frank Rauch (Montreal, Canada) (Meeting Chair)
Nick Bishop (Sheffield, UK)
Alison Boyce (Bethesda, US)
Antonella Forlino (Pavia, Italy)
Gabriele Häusler (Vienna, Austria)
Wolfgang Högler (Linz, Austria)
Alex Ireland (Manchester, UK)
Outi Mäkitie (Helsinki, Finland)
Ciara McDonnell (Dublin, Ireland)
Craig Munns (Sydney, Australia)
Leanne Ward (Ottawa, Canada)